# Optimization Strategies for Blood Transfusion Protocols in the Emergency Treatment of Hemorrhagic Shock

> **NCT07129031** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Xijing Hospital** · enrollment: 180 (estimated)

## Conditions studied

- Hemorrhage
- Hemorrhagic Shock
- Upper Gastrointestinal Bleeding (UGIB)

## Interventions

- **DRUG:** low-titer O-group whole blood
- **DRUG:** 1:1:1 component transfusion
- **DRUG:** ABO- and Rh-compatible whole blood

## Key facts

- **NCT ID:** NCT07129031
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07129031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07129031, "Optimization Strategies for Blood Transfusion Protocols in the Emergency Treatment of Hemorrhagic Shock". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07129031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*